Skip to main content
Log in

Obstetric patients’ perspectives on functional magnetic neuroimaging research in pregnant women

  • Short Communication
  • Published:
Archives of Women's Mental Health Aims and scope Submit manuscript

Abstract

Magnetic resonance neuroimaging (MRI) studies of healthy pregnant women could identify key mechanisms of spontaneous health behavior changes observed in expectant mothers as novel intervention targets, but are currently unprecedented. As balancing potential benefits of research with unknown risks, including participant perceptions of risk, is foundational to ethical conduct, we surveyed a convenience obstetric sample to understand pregnant women’s perspectives on this issue. Respondents were 76 pregnant women (modal age of 30–39 years; 64% multiparous) presenting for obstetric care from April to June 2016 at privately and publicly funded clinics at an urban academic medical center in the Midwestern USA. Following a written description about functional magnetic resonance neuroimaging (fMRI) and its known and unknown risks, women were queried on their willingness to participate in a hypothetical study involving fMRI during pregnancy, and specific concerns about doing so, if hesitant or unwilling. Willingness to participate was “yes” (28.4%, n = 21), “maybe” (28.4%, n = 21), and “no” (43.2%, n = 32). Among those responding “maybe” or “no” (n = 53, 73.6%), 11 women (20.7%) articulated concern about the fetus. Other concerns expressed were time commitment (n = 11, 20.7%) and discomfort being in an MRI machine (n = 4; 7.5%). Pregnant women may be open to participating in research involving MRI provided concerns about fetal health, time, and personal comfort are addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  • Copel J, El-Sayed Y, Heine RP, Wharton KR (2016) Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 127:E75–E80

    Article  Google Scholar 

  • Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14:537–546

    Article  CAS  Google Scholar 

  • Crozier SR, Robinson SM, Borland SE, Godfrey KM, Cooper C, Inskip HM (2009) Do women change their health behaviours in pregnancy? Findings from the Southampton Women’s Survey. Paediatr Perinat Epidemiol 23:446–453

    Article  Google Scholar 

  • Griffiths PD et al (2016) Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre. In: Prospective cohort study the lancet

    Google Scholar 

  • Hoekzema E, Barba-Müller E, Pozzobon C, Picado M, Lucco F, García-García D, Soliva JC, Tobeña A, Desco M, Crone EA, Ballesteros A, Carmona S, Vilarroya O (2017) Pregnancy leads to long-lasting changes in human brain structure. Nat Neurosci 20:287–296. https://doi.org/10.1038/nn.4458

    Article  CAS  PubMed  Google Scholar 

  • Kendler KS, Ohlsson H, Svikis DS, Sundquist K, Sundquist J (2017) The protective effect of pregnancy on risk for drug abuse: a population, co-relative, co-spouse, and within-individual analysis. Am J Psychiatr 174:954–962

    Article  Google Scholar 

  • Kim P, Leckman JF, Mayes LC, Feldman R, Wang X, Swain JE (2010) The plasticity of human maternal brain: longitudinal changes in brain anatomy during the early postpartum period. Behav Neurosci 124:695–700

    Article  Google Scholar 

  • Massey SH, Wisner KL (2018) Understanding pregnancy's protective effect on drug use within a developmental framework American Journal of Psychiatry 175(3):286–287

  • Massey SH, Decety J, Wisner KL, Wakschlag LS (2017) Specification of change mechanisms in pregnant smokers for malleable target identification: a novel approach to a tenacious public health problem. Front Public Health 5:1–12

    Article  Google Scholar 

  • Massey SH, Lieberman DZ, Reiss D, Leve LD, Shaw DS, Neiderhiser JM (2011) Association of clinical characteristics and cessation of tobacco, alcohol, and illicit drug use during pregnancy. Am J Addict 20:143–150

    PubMed  Google Scholar 

  • Massey SH, Neiderhiser JM, Shaw DS, Leve LD, Ganiban JM, Reiss D (2012) Maternal self concept as a provider and cessation of substance use during pregnancy. Addict Behav 37:956–961

    Article  Google Scholar 

  • Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL (2016) Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA 316:952–961

    Article  Google Scholar 

  • Riddle M (2015) News from the NIH (Science of Behavior Change Working Group): using an experimental medicine approach to facilitate translational research. Translational Behavioral Medicine 5:486–488

    Article  Google Scholar 

  • Rutherford HJ, Maupin AN, Landi N, Potenza MN, Mayes LC (2017) Current tobacco-smoking and neural responses to infant cues in mothers. Parenting 17:1–10

    Article  Google Scholar 

  • Smith YR, Johnson AM, Newman LA, Greene A, Johnson TR, Rogers JL (2007) Perceptions of clinical research participation among African American women. J Women's Health (Larchmt) 16:423–428. https://doi.org/10.1089/jwh.2006.0124

    Article  Google Scholar 

  • Solomon L, Quinn V (2004) Spontaneous quitting: self-initiated smoking cessation in early pregnancy. Nicotine Tob Res 6(Suppl 2):S203–S216. https://doi.org/10.1080/14622200410001669132

    Article  PubMed  Google Scholar 

  • Sonuga-Barke EJ (2017) Commentary: extraordinary environments, extreme neuroplasticity and mental disorder–reflections on pathways from adversity to mental disorder prompted by McCrory, Gerin, and Viding (2017). J Child Psychol Psychiatry 58:358–360

    Article  Google Scholar 

  • Volkow ND (2014) America’s addiction to opioids: heroin and prescription drug abuse Senate Caucus on International Narcotics Control 14

  • Voos A, Pelphrey K (2013) Functional magnetic resonance imaging. J Cogn Dev 14:1–9

    Article  Google Scholar 

Download references

Acknowledgements

We thank all participants and obstetric staff who made this study possible.

Funding

This study was supported by grant 5K23 DA 037913 from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) to Dr. Massey. NIDA and NIH had no role in the study design, data collection, analysis or interpretation of the data, or the decision to submit this work for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suena H. Massey.

Ethics declarations

Conflict of interest

The Department of Psychiatry at Northwestern University receives contractual fees for Dr. Wisner’s consultation to Quinn Emanuel Urquhart and Sullivan, LLP (New York City), who represents Pfizer Pharmaceutical Company. Authors Newmark, Zaydlin, Yang, Kuchenrither, and Massey have no conflicts of interest to report.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Newmark, R.L., Zaydlin, M.L., Yang, A. et al. Obstetric patients’ perspectives on functional magnetic neuroimaging research in pregnant women. Arch Womens Ment Health 22, 115–118 (2019). https://doi.org/10.1007/s00737-018-0846-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00737-018-0846-x

Keywords

Navigation